Results 201 to 210 of about 1,021,856 (349)
Coronary Heart Disease Attributable to Psychosocial Stressors at Work. [PDF]
Lavigne-Robichaud M +18 more
europepmc +1 more source
A Network Pharmacology Analysis to Reveal the Molecular Mechanism of Zhizi-Danshen on Coronary Heart Disease [PDF]
Yuehong Shen +5 more
openalex +1 more source
Comprehending the Membrane Properties for Emulation in Organs‐on‐a‐Chip
The advent of organ‐on‐chip models allows closer emulation of in vivo conditions, leading to effective, less costly, and specific drugs. Although a number of membrane‐based on‐chip models exist, better emulating functional models need to be devised for organ simulations.
Tanmayee Makarand Sathe +1 more
wiley +1 more source
Polygenic prediction of coronary heart disease among 130,000 Mexican adults. [PDF]
Liu T +19 more
europepmc +1 more source
This review explores how surface‐coated inorganic nanomaterials are chemically engineered for advanced drug delivery. It highlights design principles, coating strategies, and biomedical applications, emphasizing how surface chemistry governs biocompatibility, targeting, and controlled release.
Hossein Daneshgar +4 more
wiley +1 more source
Atrial arrhythmias related to antitumor treatment in patients with coronary heart disease and malignant tumors. [PDF]
Zhang B, Zhang L, Ren Y, Xu C.
europepmc +1 more source
Mucin Glycoprotein Nanoparticles Enable a Selective Antisense Therapy for Oncogenic MicroRNAs
Mucin glycoproteins are turned into nanoparticles by employing synthetic DNA strands, which have a dual function: they stabilize the nanoparticles and act as binding sites for intracellular miRNA‐21. Thus, upon internalization into tumor cells, these mucin nanoparticles can deplete miRNA‐21 from the cytosol, which induces apoptosis in vitro and in vivo.
Ceren Kimna +9 more
wiley +1 more source
The Mediterranean Diet in Primary and Secondary Prevention of Coronary Heart Disease: Evidence and Mechanisms. [PDF]
Młynarska E +7 more
europepmc +1 more source

